TITLE

Emergent BioSolutions Receives $44 Million CDC Contract

PUB. DATE
September 2015
SOURCE
Contract Pharma;Sep2015, Vol. 17 Issue 7, p149
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the $44 million worth of contract given to biopharmaceutical company Emergent BioSolutions Inc. from the U.S. Centers for Disease Control and Prevention (CDC) to supply Vaccinia Immune Globulin (VIGIV) antibodies.
ACCESSION #
109365571

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics